{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:05:44Z","timestamp":1793171144424,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1I1A1A01061253"],"award-info":[{"award-number":["2019R1I1A1A01061253"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022R1A2C1006621"],"award-info":[{"award-number":["2022R1A2C1006621"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121201","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T01:28:21Z","timestamp":1668562101000},"page":"121201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"PB","title":["LPA\/LPAR1 signaling induces PGAM1 expression via AKT\/mTOR\/HIF-1\u03b1 pathway and increases aerobic glycolysis, contributing to keratinocyte proliferation"],"prefix":"10.1016","volume":"311","author":[{"given":"Donghee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu Phyu","family":"Khin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Kyung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sook","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.lfs.2022.121201_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.lfs.2022.121201_bb0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-012-8305-3","article-title":"Clinical and histologic diagnostic guidelines for psoriasis: a critical review","volume":"44","author":"Johnson","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121201_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: keratinocytes or immune cells - which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.lfs.2022.121201_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: a trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2022.121201_bb0025","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2022.121201_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prostaglandins.2009.02.002","article-title":"Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance","volume":"91","author":"Lin","year":"2010","journal-title":"Prostaglandins Other Lipid Mediators"},{"issue":"7","key":"10.1016\/j.lfs.2022.121201_bb0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.121201_bb0040","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jid.2018.10.034","article-title":"LPA induces keratinocyte differentiation and promotes skin barrier function through the LPAR1\/LPAR5-RHO-ROCK-SRF axis","volume":"139","author":"Sumitomo","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2022.121201_bb0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lfs.2018.12.040","article-title":"The role of lysophosphatidic acid in the physiology and pathology of the skin","volume":"220","author":"Lei","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.121201_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-020-00379-1","article-title":"Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5","volume":"6","author":"Lei","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.lfs.2022.121201_bb0055","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/cells9081753","article-title":"Lysophosphatidic acid receptor 5 contributes to imiquimod-induced psoriasis-like lesions through NLRP3 inflammasome activation in macrophages","volume":"9","author":"Gaire","year":"2020","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.lfs.2022.121201_bb0060","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.3390\/ijms221910777","article-title":"Lysophosphatidic acid mediates imiquimod-induced psoriasis-like symptoms by promoting keratinocyte proliferation through LPAR1\/ROCK2\/PI3K\/AKT signaling pathway","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.121201_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"issue":"5930","key":"10.1016\/j.lfs.2022.121201_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.121201_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2015.00227","article-title":"Aerobic glycolysis: beyond proliferation","volume":"6","author":"Jones","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121201_bb0080","article-title":"Pyruvate kinase M2 mediates glycolysis contributes to psoriasis by promoting keratinocyte proliferation","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121201_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800119","article-title":"The proteomic profile of keratinocytes and lymphocytes in psoriatic patients","volume":"13","author":"Gegotek","year":"2019","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.lfs.2022.121201_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-416618-9.00005-4","article-title":"Techniques to monitor glycolysis","volume":"542","author":"TeSlaa","year":"2014","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121201_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-022-00814-1","article-title":"Inhibition of ChREBP ubiquitination via the ROS\/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells","volume":"29","author":"Kim","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2022.121201_bb0100","first-page":"5789","article-title":"Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications","volume":"35","author":"Cazzaniga","year":"2015","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.121201_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152016","article-title":"Determining maximum glycolytic capacity using extracellular flux measurements","volume":"11","author":"Mookerjee","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121201_bb0110","first-page":"227","article-title":"The phosphoglycerate mutases","volume":"62","author":"Fothergill-Gilmore","year":"1989","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2022.121201_bb0115","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/ijc.28637","article-title":"The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications","volume":"135","author":"Jiang","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2022.121201_bb0120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"issue":"19","key":"10.1016\/j.lfs.2022.121201_bb0125","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2022.121201_bb0130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/0008-5472.CAN-17-1624","article-title":"LPA induces metabolic reprogramming in ovarian cancer via a pseudohypoxic response","volume":"78","author":"Ha","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121201_bb0135","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/ijms22041968","article-title":"Lysophosphatidic acid induces aerobic glycolysis, lipogenesis, and increased amino acid uptake in BV-2 microglia","volume":"22","author":"Joshi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2022.121201_bb0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neo.2015.09.003","article-title":"Lysophosphatidic acid up-regulates hexokinase II and glycolysis to promote proliferation of ovarian cancer cells","volume":"17","author":"Mukherjee","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.lfs.2022.121201_bb0145","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.canlet.2018.11.023","article-title":"Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts","volume":"442","author":"Radhakrishnan","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2022.121201_bb0150","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/ncomms2759","article-title":"Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation","volume":"4","author":"Hitosugi","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2022.121201_bb0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41418-017-0034-y","article-title":"Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.lfs.2022.121201_bb0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccr.2012.09.020","article-title":"Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth","volume":"22","author":"Hitosugi","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.121201_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.082","article-title":"Phosphoglycerate mutase 1 activates DNA damage repair via regulation of WIP1 activity","volume":"31","author":"Ohba","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2022.121201_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.844861","article-title":"PKM2 interacts with the Cdk1-CyclinB complex to facilitate cell cycle progression in gliomas","volume":"12","author":"Ohba","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121201_bb0175","first-page":"854","article-title":"Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPARbeta\/delta in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model","volume":"96","author":"Chamcheu","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"9","key":"10.1016\/j.lfs.2022.121201_bb0180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice","volume":"97","author":"Burger","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121201_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1alpha pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.lfs.2022.121201_bb0190","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41467-020-15795-8","article-title":"Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT\/mTOR\/HIF1alpha pathway suppression","volume":"11","author":"Weng","year":"2020","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.lfs.2022.121201_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo2295","article-title":"Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression","volume":"8","author":"Abu El Maaty","year":"2022","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.lfs.2022.121201_bb0200","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121201_bb0205","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/ijms23031693","article-title":"Predominant role of mTOR signaling in skin diseases with therapeutic potential","volume":"23","author":"Karagianni","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.121201_bb0210","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121201_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.69","article-title":"Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis","volume":"3","author":"Madonna","year":"2012","journal-title":"Cell Death Dis."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:55Z","timestamp":1758402175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522009018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":43,"alternative-id":["S0024320522009018"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121201","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LPA\/LPAR1 signaling induces PGAM1 expression via AKT\/mTOR\/HIF-1\u03b1 pathway and increases aerobic glycolysis, contributing to keratinocyte proliferation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121201"}}